Tag: Alzheimer
Cortexyme: Addressing Unmet Needs in the Alzheimer’s Market
The stocks of Cortexyme, Inc (NASDAQ: CRTX), a clinical stage biopharmaceutical company engaged in developing novel therapeutics for Alzheimer’ disease, surged by almost 70%...
Curaleaf Holding: Forging the largest acquisition in U.S cannabis landscape
The shares of Curaleaf (OTCQX: CURLF) surged by almost 15% since the news of its acquisition of Cura Partners, the owner of Select brand, in...
Recent Advances in Gene Therapy and Small Molecule Inhibitors show promise...
Sjogren’s, named after its discoverer Henrik Sjögren, is the most prevalent systemic autoimmune disease that predominantly affects women. This disorder is manifested in the...
Acreage Holdings – “On a High” with news of Acquisition by...
The Canadian cannabis behemoth Canopy Growth Inc (NYSE:CGC), a global leader in diversified cannabis and hemp related products, entered into a definitive agreement with Acreage Holdings,...
Fighting Parkinson’s: Novel Therapeutics could prove to be game-changers
Parkinson’s is the second most common age-related neurodegenerative disorder, characterized by muscle rigidity, bradykinesia, cognitive impairment, etc. An estimated one million people in the...
Companies Pioneering Novel Solutions to Tackle Obesity
Obesity and overweight together are the leading cause of preventable death in the U.S leading to a loss of 47 percent more life years...
We are looking for talented interns to learn and help investors find valuable companies.